Fresenius SE & Co. KGaA (FRE.DE)
EUR 34.19
(0.41%)
EUR 34.19
(0.41%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 13.54 Billion EUR | -47.08% |
| 2022 | 25.58 Billion EUR | 4.25% |
| 2021 | 24.54 Billion EUR | 1.95% |
| 2020 | 24.07 Billion EUR | -5.97% |
| 2019 | 25.6 Billion EUR | 55.88% |
| 2018 | 16.42 Billion EUR | -5.64% |
| 2017 | 17.4 Billion EUR | 30.65% |
| 2016 | 13.32 Billion EUR | -2.93% |
| 2015 | 13.72 Billion EUR | -4.48% |
| 2014 | 14.36 Billion EUR | 20.02% |
| 2013 | 11.97 Billion EUR | 17.27% |
| 2012 | 10.2 Billion EUR | 89.51% |
| 2011 | 5.38 Billion EUR | -37.13% |
| 2010 | 8.56 Billion EUR | 59.93% |
| 2009 | 5.35 Billion EUR | 298.07% |
| 2008 | 1.34 Billion EUR | 472.85% |
| 2007 | -361 Million EUR | -38.31% |
| 2006 | -261 Million EUR | -3.57% |
| 2005 | -252 Million EUR | -80.0% |
| 2004 | -140 Million EUR | -2100.0% |
| 2003 | 7 Million EUR | -98.23% |
| 2002 | 395 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 13.48 Billion EUR | -0.41% |
| 2024 Q2 | 12.42 Billion EUR | -7.84% |
| 2023 Q1 | 25.44 Billion EUR | -0.56% |
| 2023 Q3 | 14.02 Billion EUR | -45.47% |
| 2023 Q4 | 13.54 Billion EUR | -3.42% |
| 2023 FY | 13.54 Billion EUR | -47.08% |
| 2023 Q2 | 25.71 Billion EUR | 1.05% |
| 2022 Q2 | 26.23 Billion EUR | 4.4% |
| 2022 Q4 | 25.58 Billion EUR | -3.36% |
| 2022 FY | 25.58 Billion EUR | 4.25% |
| 2022 Q1 | 25.13 Billion EUR | 2.4% |
| 2022 Q3 | 26.47 Billion EUR | 0.91% |
| 2021 Q4 | 24.54 Billion EUR | -0.94% |
| 2021 Q1 | 24.63 Billion EUR | 2.31% |
| 2021 FY | 24.54 Billion EUR | 1.95% |
| 2021 Q2 | 25.03 Billion EUR | 1.66% |
| 2021 Q3 | 24.77 Billion EUR | -1.04% |
| 2020 Q2 | 24.41 Billion EUR | -7.97% |
| 2020 Q3 | 24.33 Billion EUR | -0.31% |
| 2020 Q4 | 24.07 Billion EUR | -1.08% |
| 2020 Q1 | 26.52 Billion EUR | 3.61% |
| 2020 FY | 24.07 Billion EUR | -5.97% |
| 2019 Q3 | 25.41 Billion EUR | -0.01% |
| 2019 FY | 25.6 Billion EUR | 55.88% |
| 2019 Q2 | 25.41 Billion EUR | 2.34% |
| 2019 Q1 | 24.83 Billion EUR | 51.2% |
| 2019 Q4 | 25.6 Billion EUR | 0.75% |
| 2018 Q2 | 16.72 Billion EUR | -5.61% |
| 2018 FY | 16.42 Billion EUR | -5.64% |
| 2018 Q4 | 16.42 Billion EUR | -0.48% |
| 2018 Q3 | 16.5 Billion EUR | -1.3% |
| 2018 Q1 | 17.71 Billion EUR | 1.78% |
| 2017 Q1 | 18.73 Billion EUR | 40.58% |
| 2017 FY | 17.4 Billion EUR | 30.65% |
| 2017 Q4 | 17.4 Billion EUR | -3.43% |
| 2017 Q3 | 18.02 Billion EUR | -2.78% |
| 2017 Q2 | 18.53 Billion EUR | -1.02% |
| 2016 Q1 | 13.66 Billion EUR | -0.42% |
| 2016 Q2 | 13.86 Billion EUR | 1.43% |
| 2016 Q3 | 13.34 Billion EUR | -3.73% |
| 2016 Q4 | 13.32 Billion EUR | -0.16% |
| 2016 FY | 13.32 Billion EUR | -2.93% |
| 2015 Q4 | 13.72 Billion EUR | -3.77% |
| 2015 FY | 13.72 Billion EUR | -4.48% |
| 2015 Q3 | 14.26 Billion EUR | -3.27% |
| 2015 Q1 | 14.94 Billion EUR | 4.03% |
| 2015 Q2 | 14.74 Billion EUR | -1.36% |
| 2014 Q2 | 13.45 Billion EUR | 4.0% |
| 2014 FY | 14.36 Billion EUR | 20.02% |
| 2014 Q4 | 14.36 Billion EUR | 3.8% |
| 2014 Q3 | 13.84 Billion EUR | 2.87% |
| 2014 Q1 | 12.94 Billion EUR | 8.09% |
| 2013 FY | 11.97 Billion EUR | 17.27% |
| 2013 Q1 | 10.17 Billion EUR | -0.34% |
| 2013 Q2 | 10.36 Billion EUR | 1.85% |
| 2013 Q3 | 10.2 Billion EUR | -1.51% |
| 2013 Q4 | 11.97 Billion EUR | 17.3% |
| 2012 Q2 | 11.02 Billion EUR | 130.16% |
| 2012 FY | 10.2 Billion EUR | 89.51% |
| 2012 Q4 | 10.2 Billion EUR | -1.41% |
| 2012 Q3 | 10.35 Billion EUR | -6.03% |
| 2012 Q1 | 4.78 Billion EUR | -11.12% |
| 2011 FY | 5.38 Billion EUR | -37.13% |
| 2011 Q2 | 8.95 Billion EUR | 11.63% |
| 2011 Q1 | 8.02 Billion EUR | -6.35% |
| 2011 Q4 | 5.38 Billion EUR | -36.82% |
| 2011 Q3 | 8.52 Billion EUR | -4.81% |
| 2010 FY | 8.56 Billion EUR | 59.93% |
| 2010 Q4 | 8.56 Billion EUR | 14.39% |
| 2010 Q3 | 7.49 Billion EUR | -15.36% |
| 2010 Q2 | 8.85 Billion EUR | 8.98% |
| 2010 Q1 | 8.12 Billion EUR | 51.57% |
| 2009 Q4 | 5.35 Billion EUR | 0.0% |
| 2009 FY | 5.35 Billion EUR | 298.07% |
| 2008 FY | 1.34 Billion EUR | 472.85% |
| 2007 FY | -361 Million EUR | -38.31% |
| 2006 FY | -261 Million EUR | -3.57% |
| 2005 FY | -252 Million EUR | -80.0% |
| 2004 FY | -140 Million EUR | -2100.0% |
| 2003 FY | 7 Million EUR | -98.23% |
| 2002 FY | 395 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 10.64 Billion EUR | -27.182% |
| LIMES Schlosskliniken AG | 1.57 Million EUR | -861746.749% |
| M1 Kliniken AG | -5.33 Million EUR | 253833.818% |
| Maternus-Kliniken Aktiengesellschaft | 111.79 Million EUR | -12011.915% |
| MEDICLIN Aktiengesellschaft | 364.53 Million EUR | -3614.56% |
| RHÖN-KLINIKUM Aktiengesellschaft | -56.2 Million EUR | 24192.163% |
| VITA 34 AG | 4.15 Million EUR | -325483.073% |